1659P Updated pathologic responses from a pilot phase II trial of neoadjuvant immunotherapy for stage II-IV resectable cutaneous squamous cell carcinoma of the head and neck (CSCC-HN).
Saved in:
| Title: | 1659P Updated pathologic responses from a pilot phase II trial of neoadjuvant immunotherapy for stage II-IV resectable cutaneous squamous cell carcinoma of the head and neck (CSCC-HN). |
|---|---|
| Authors: | Amit, M.1 (AUTHOR), Ferrarotto, R.2 (AUTHOR), Nagarajan, P.3 (AUTHOR), Li, G.1 (AUTHOR), Yuan, Y.4 (AUTHOR), Morrison, W.5 (AUTHOR), Rosenthal, D.5 (AUTHOR), de Sousa, L.2 (AUTHOR), Johnson, F.2 (AUTHOR), Diaz, E.1 (AUTHOR), Gidley, P.1 (AUTHOR), Lewis, C.1 (AUTHOR), Myers, J.5 (AUTHOR), Gross, N.1 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS982-S982. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2287 |
